nemonoxacin   Click here for help

GtoPdb Ligand ID: 10836

Synonyms: Taigexyn® | TG-873870 | TG873870
Approved drug
nemonoxacin is an approved drug (Taiwan (2014))
Compound class: Synthetic organic
Comment: Nemonoxacin is a non-fluorinated quinolone antibacterial with broad-spectrum activity against Gram-positive and Gram-negative bacteria and atypical pathogens, including methicillin-resistant S. aureus (MRSA) and vancomycin-resistant pathogens [1-2]. It selectively inhibits bacterial DNA topoisomerase (DNA gyrase) activity.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 97.79
Molecular weight 371.18
XLogP 4.25
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1c(ccc2c1n(cc(c2=O)C(=O)O)C1CC1)N1C[C@@H](C)C[C@@H](C1)N
Isomeric SMILES COc1c(ccc2c1n(cc(c2=O)C(=O)O)C1CC1)N1C[C@@H](C)C[C@@H](C1)N
InChI InChI=1S/C20H25N3O4/c1-11-7-12(21)9-22(8-11)16-6-5-14-17(19(16)27-2)23(13-3-4-13)10-15(18(14)24)20(25)26/h5-6,10-13H,3-4,7-9,21H2,1-2H3,(H,25,26)/t11-,12-/m0/s1
InChI Key AVPQPGFLVZTJOR-RYUDHWBXSA-N
References
1. Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR. (2009)
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
J Antimicrob Chemother, 64 (6): 1226-9. [PMID:19833635]
2. Chotikanatis K, Kohlhoff SA, Hammerschlag MR. (2014)
In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.
Antimicrob Agents Chemother, 58 (3): 1800-1. [PMID:24366753]
3. Lauderdale TL, Shiau YR, Lai JF, Chen HC, King CH. (2010)
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.
Antimicrob Agents Chemother, 54 (3): 1338-42. [PMID:20065058]
4. Poole RM. (2014)
Nemonoxacin: first global approval.
Drugs, 74 (12): 1445-53. [PMID:25079302]